GBGrzegorz Biolik

Grzegorz Biolik

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Grzegorz Biolik has a total of 52 co-authors. Here are the top co-authors by number of shared publications:

  • Krzysztof Ziaja

    Department of General, Vascular Surgery, Angiology and Phlebology Faculty of Katowice Medical University of Silesia, Faculty of Medicine in Katowice, Medical University of Silesia, Poniatowskiego Str 15, 40-055 Katowice, Poland

    8 shared publications
  • Damian Ziaja

    C Faculty of Medicine in Katowice , Unit of Physiology, School of Health Care, Medical University of Silesia , Katowice , Poland

    7 shared publications
  • Krzysztof Pawlicki

    D Department of Biophysics, Faculty of Medicine in Katowice , School of Health Science Medical University of Silesia , Katowice , Poland

    6 shared publications
  • Jan Duława

    Department of Internal Medicine and Metabolic Diseases, Faculty of Health Sciences in Katowice, Medical University of Silesia, Katowice, Poland

    5 shared publications
  • Jerzy Chudek

    Department of Internal Medicine and Oncological Chemotherapy, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Poland

    4 shared publications
  • Mariola Sznapka

    A Department of General Vascular Surgery, Faculty of Medicine in Katowice , School of Health Science, Medical University of Silesia , Katowice , Poland

    4 shared publications

Latest Publications

  • Open Access

    Endothelial function/damage markers and NGAL – intraoperative assessment in blood specimens obtained from different sampling sites during open repair of abdominal aortic aneurysm

    by Michał Kokot, Grzegorz Biolik, Anna Kokot, Leszek Kędzierski, Tadeusz Fojt, Damian Ziaja, Krzysztof Ziaja, Jan Duława

    WPROWADZENIE: Celem pracy było zbadanie dynamiki zmian stężenia lipokainy związanej z żelatynazą neutrofilów (neutrophil gelatinase-associated lipocalin – NGAL), która jest wskaźnikiem ostrego uszkodzenia nerek, oraz wskaźników czynności/uszkodzenia śródbłonka: selektyny P, cząsteczki adhezji międzykomórkowej 1 (intercellular adhesion molecule 1 – ICAM-1), cząstki adhezyjnej śródbłonka naczyniowego 1 (vascular cell adhesion molecule 1 – VCAM-1) i czynnika von Willebranda (von Willebrand factor – vWf) w próbkach krwi pobieranych z różnych obszarów naczyniowych podczas elektywnej operacji naprawczej tętniaka aorty brzusznej (abdominal aortic aneurysm – AAA) metodą otwartą.MATERIAŁ I METODY: Badanie objęło grupę 33 chorych zakwalifikowanych do planowego zabiegu metodą otwartą (open repair – ORe). Wszystkie wymienione parametry oznaczono w próbkach krwi pobranych: 1) przed zabiegiem z żyły łokciowej oraz w trakcie zabiegu; 2) z żyły nerkowej przed założeniem zacisku aorty; 3) z żyły nerkowej bezpośrednio przed zwolnieniem zacisku aorty; 4) z żyły łokciowej bezpośrednio przed zwolnieniem zacisku aorty; 5) z żyły głównej dolnej bezpośrednio przed zwolnieniem zacisku aorty; 6) z żyły nerkowej w 5 minucie po zwolnieniu zacisku aorty; 7) z żyły łokciowej w 5 minucie po zwolnieniu zacisku aorty.WYNIKI: Stwierdzono zmniejszenie stężenia selektyny P, ICAM-1 i VCAM-1 w próbkach pobranych z żyły łokciowej bezpośrednio przed zdjęciem zacisku aorty oraz 5 minut po zdjęciu zacisku aorty w porównaniu z wartościami przed zabiegiem. Ponadto obserwowano nagłe zmiany stężenia NGAL, vWf i VCAM-1 podczas zabiegu.WNIOSKI: Uzyskane wyniki wydają się przemawiać za rozwojem stanu zapalnego już w trakcie zabiegu operacyjnego AAA metodą otwartą.

  • Open Access

    Potential benefits of blood flow restriction training in patients with type 2 diabetes: A narrative literature review

    by Robert Trybulski, Filipe Manuel Clemente, Grzegorz Biolik, Michał Wilk, Adrian Kużdżał

    Study aim: This narrative review aims to critically discuss the potential beneficial effects of blood flow restriction (BFR) training on physiological outcomes, including muscle metabolism, insulin sensitivity, glucose metabolism, body composition, and cardiovascular health in type 2 diabetic individuals. Material and methods: A comprehensive literature search was conducted across PubMed, Scopus, SPORTDiscus, and Google Scholar for studies published before December 10, 2025, using key terms related to BFR and diabetes. Results: A total of 11 studies were included in this review after screening for relevance. These studies employed various BFR protocols and examined outcomes such as glycemic control, insulin sensitivity, body composition, and cardiovascular function in individuals with type 2 diabetes. BFR training was found to improve insulin sensitivity, reduce blood glucose levels, improve muscle metabolism, and positively influence body composition in individuals with type 2 diabetes. Several studies observed significant improvements in aerobic capacity (e.g., VO2 max) and fat mass reductions. Additionally, BFR training demonstrated improvements in blood pressure regulation. However, variability in BFR protocols and short-term study durations limit the generalizability of these findings. Conclusions: Preliminary findings suggest that BFR training may be effective as a non-pharmacological intervention for improving determinant metabolic and cardiovascular health outcomes in type 2 diabetes individuals, including insulin sensitivity, glucose metabolism, and cardiorespiratory fitness. Further research is needed to determine this training modality’s optimal BFR parameters and long-term effects in diabetic populations.


  • Open Access

    Application of deep oscillation therapy in the treatment of peripheral arterial diseases

    by R. Trybulski, G. Biolik, W. Kuczmik, N. Ivasyk, O. Tyravska

    Intermittent claudication is a common symptom of peripheral arterial disease, affecting up to 50% of patients over the age of 50, which is characterized by pain, discomfort, and cramping in the leg muscles during physical activity. Intermittent claudication is a common symptom of lower extremity arterial disease (LEAD), which significantly impacts patients’ quality of life and drives healthcare costs. Current treatments for intermittent claudication are often inadequate, leading to a need for more effective treatments. Developing new treatments is critical to improve outcomes for patients and address the public health implications of LEAD. This study’s aim was to present the impact of comprehensive physiotherapy, conducted independently, with the supervision of a physiotherapist, for 14 weeks, on a patient with intermittent claudication caused by peripheral arterial disease. The therapy included bicycle training in a form of physical therapy at home, combined with deep oscillation therapy. Deep oscillation therapy involved the use of an electrostatic field with a frequency of 5 to 250 Hz. The field was applied following the lymphatic drainage methodology. In the discussed case, a statistically significant and favourable increase in the measured variables was observed, such as the increase of bone-brachial index from 0.65 to 0.8, the increase of tissue perfusion, measured by laser Doppler flowmetry, from 12.3% to 61%, depending on the measurement site, and the increase in pain-free walking distance by 451%. TcPO2 measurement in the affected leg increased from 31 to 48 mmHg. The use of physical therapy at home combined with deep oscillation showed improvements in pain-free walking distance, Ankle Brachial Index, and other measures in patients with peripheral arterial disease. Deep oscillation therapy demonstrated potential analgesic effects but also raised concerns about possible nerve damage. The study indicated that physical therapy at home might serve as an alternative to supervised exercise therapy, but it had limitations like a small sample size and lack of direct comparisons.


  • Open Access

    The Influence of Inflammation on Fibrinogen Turnover and Redistribution of the Hemostatic Balance to a Prothrombotic State in High On-Treatment Platelet Reactivity-Dual Poor Responder (HTPR-DPR) Patients

    by Grzegorz Biolik, Dariusz Gajniak, Maciej Kubicz, Damian Ziaja, Krzysztof Ziaja, Wacław Kuczmik

    Knowledge about the influence of inflammation on platelet function and relocation of hemostatic balance to hypercoagulable state is still unclear. We compared two groups of patients who suffer from acute vs. chronic inflammatory process and additionally present high on-treatment platelet reactivity-dual platelet resistance. We did not found any differences in platelet aggregation between both investigated groups, but patients who suffer from chronic inflammation presented stronger relocation of the hemostatic balance to the hypercoagulability. A high concentration of prothrombin fragment F1+2 together with higher activity of von Willebrand factor in critical limb ischemia shows more exaggerated fibrinogen turnover although the blood concentration of this factor was in normal range. We concluded that high on-treatment platelet reactivity-dual platelet resistance and intensified inflammation are linked with elevated platelet and fibrinogen turnover to counteract proper hemostatic balance in favor of a prothrombotic state.


  • Concentration of neutrophil gelatinase-associated lipocalin (NGAL) in serum obtained from different vascular areas during surgical repair of abdominal aortic aneurysm

    by Leszek Kędzierski, Michał Kokot, Grzegorz Biolik, Damian Ziaja, Krzysztof Ziaja, Jan Duława

    Wstęp: Lipokalina związana z żelatynazą granulocytów obojętnochłonnych (neutrophil gelatinase-associated lipocalin – NGAL) jest białkiem sekrecyjnym znajdującym się w ziarnistościach granulocytów obojętnochłonnych, w komórkach śródbłonka oraz w różnych narządach układów oddechowego, pokarmowego, wydalniczego i rozrodczego. Zaangażowana w procesy zapalne w komórkach, uważana jest za jeden z najbardziej miarodajnych wczesnych wskaźników dysfunkcji nerek. Klasyczny zabieg naprawczy tętniaka aorty brzusznej można potraktować jako model badawczy ostrego uszkodzenia nerek. Podczas tej interwencji chirurgicznej dochodzi do jatrogennego uszkodzenia nerek. Technika zabiegu umożliwia pobranie krwi do badania z różnych obszarów naczyniowych.Materiał i metody: Badaniem objęto 21 chorych z tętniakiem aorty brzusznej, zakwalifikowanych do planowego leczenia chirurgicznego metodą klasyczną. W celu określenia stężenia NGAL w surowicy pobierano krew: z żyły obwodowej przed zabiegiem, bezpośrednio przed zwolnieniem zacisku z aorty, 5 minut po zwolnieniu zacisku z aorty, z żyły nerkowej bezpośrednio przed założeniem zacisku na aortę, bezpośrednio przed zwolnieniem zacisku z aorty, 5 minut po zwolnieniu zacisku z aorty, z żyły głównej dolnej bezpośrednio przed zwolnieniem zacisku z aorty.Wyniki: Stężenie NGAL w surowicy uzyskanej z żyły obwodowej zwiększyło się istotnie po zabiegu. Bezpośrednio przed zwolnieniem zacisku z aorty odnotowano istotnie większe stężenie NGAL w surowicy uzyskanej z żyły głównej dolnej niż z żyły nerkowej.Wnioski: Zwiększenie stężenia NGAL w surowicy po zabiegu naprawczym tętniaka aorty brzusznej spowodowane jest większym napływem tej cytokiny do krążenia ogólnego z obszarów naczyniowych dolnej części ciała, niedokrwionej z powodu zaciśnięcia aorty.

  • Platelet reactivity in thromboelastometry. Revision of the FIBTEM test: a basic study

    by Grzegorz Biolik, Michał Kokot, Mariola Sznapka, Agnieszka Święszek, Damian Ziaja, Krzysztof Pawlicki, Krzysztof Ziaja

    This study aimed to investigate modifications to the FIBTEM test to better assess fibrinogen levels and the quality of fibrin polymerization in citrated blood using Multiplate impedance aggregometry to verify platelet inhibition. Blood samples from 26 healthy volunteers were subjected to thromboelastometry studies (EXTEM/FIBTEM tests) in accordance with the standard study protocol (cytochalasin D) and according to a modified protocol (synthetic IIbIIIa receptor antagonist vs. acetylsalicylic acid [ASA] + synthetic IIbIIIa receptor antagonist instead of cytochalasin D). Independent of thromboelastometry, Multiplate impedance aggregometry was used to assess the degree of restriction by the platelet blocked with the following treatments: (1) cytochalasin D, (2) synthetic IIbIIIa antagonist or (3) ASA + synthetic IIbIIIa antagonist to assess the aggregation response to activation with an agonist (ADP, collagen, thrombin receptor activating peptide-6 [TRAP-6], and arachidonic acid). Via aggregometry, cytochalasin D more weakly inhibited platelet aggregation than simultaneous administration of the -IIbIIIa receptor antagonist with ASA. However, total platelet aggregation inhibition was observed after simultaneous administration of cytochalasin D combined with a synthetic IIbIIIa receptor antagonist. In the thromboelastometry, a significant decrease of the A10, A20 and MCF parameters were observed in the EXTEM/FIBTEM tests after they were modified by the addition of a synthetic IIbIIIa receptor antagonist alone or in combination with ASA. In conclusion, in this Multiplate- and ROTEM-based laboratory approach, a two-way blockade (IIbIIIa-antagonist + cytochalasine D) was sufficient to completely inhibit procoagulant platelet function as observed by aggregometry and thromboelastometry.


  • Open Access

    Regional variations of symptoms of the chronic venous disease among primary health care patients in Poland

    by Damian Ziaja, Mariola Sznapka, Joanna Grzela, Jacek Kostecki, Grzegorz Biolik, Krzysztof Pawlicki, Krzysztof Ziaja, Jerzy Chudek, Marek Maruszynski, Aleksander Molski, et al.

    Introduction. The diverse social and cultural contexts may cause differences in perceiving symptoms of the chronic venous disease (ChVD), not only in global, European terms, but also in a regional context. The purpose of the study was to find the regional differences of the reported symptoms and the applied conservative treatment methods among patients with ChVD diagnosed by the primary health care (PHC) doctors in Poland. Material and methods. 13 393 patients participated in the multi-centre PHLEBOS-2 research carried out by 330 PHC doctors in 15 voivodeships. Results. In the study group of patients, 31.9% of patients had ChVD symptoms – the C0 stage, telangiec­tasias and venulectasias (C1 stage) occurred among 56.1% of patients, varices without symptoms of venous insufficiency occurred among 6% of patients and venous insufficiency among 6% of patients. Venous ulcers (active or healed) occurred among 0.6% of subjects. Essential differences in the ChVD structure between voivodeships were noted. Among the most frequently reported ChVD ailments were heaviness of legs (72.9%), ankle swelling in the eve­nings (68.4%) and nighttime leg cramps (58.6%). Leg swelling during the night hours occurred less frequently — 39.8%, paraesthesias — 30.4%, restless legs syndrome — 18.6%. The average intensity of calf pain was moderate (3.82 ± 1.86 points in the 10 point scale). The territorial diversity in the prevalence of symptoms was significant and resulted neither from the ChVD seriousness, nor from the age of the patients. Compression therapy was applied on average by 12.5% of patients and 24.8% of patients used phlebotropic drugs with large territorial variations (respectively from 3.4% to 28.8% and from 11.2 to 56.1%). The differences between the voivodeships were greater than the regional differences and did not depend on the ChVD stage. Conclusions. There are significant territorial variations in Poland in the frequency of the reported symptoms and in the conservative therapy of the chronic venous disease. Introduction. The diverse social and cultural contexts may cause differences in perceiving symptoms of the chronic venous disease (ChVD), not only in global, European terms, but also in a regional context. The purpose of the study was to find the regional differences of the reported symptoms and the applied conservative treatment methods among patients with ChVD diagnosed by the primary health care (PHC) doctors in Poland. Material and methods. 13 393 patients participated in the multi-centre PHLEBOS-2 research carried out by 330 PHC doctors in 15 voivodeships. Results. In the study group of patients, 31.9% of patients had ChVD symptoms – the C0 stage, telangiec­tasias and venulectasias (C1 stage) occurred among 56.1% of patients, varices without symptoms of venous insufficiency occurred among 6% of patients and venous insufficiency among 6% of patients. Venous ulcers (active or healed) occurred among 0.6% of subjects. Essential differences in the ChVD structure between voivodeships were noted. Among the most frequently reported ChVD ailments were heaviness of legs (72.9%), ankle swelling in the eve­nings (68.4%) and nighttime leg cramps (58.6%). Leg swelling during the night hours occurred less frequently — 39.8%, paraesthesias — 30.4%, restless legs syndrome — 18.6%. The average intensity of calf pain was moderate (3.82 ± 1.86 points in the 10 point scale). The territorial diversity in the prevalence of symptoms was significant and resulted neither from the ChVD seriousness, nor from the age of the patients. Compression therapy was applied on average by 12.5% of patients and 24.8% of patients used phlebotropic drugs with large territorial variations (respectively from 3.4% to 28.8% and from 11.2 to 56.1%). The differences between the voivodeships were greater than the regional differences and did not depend on the ChVD stage. Conclusions. There are significant territorial variations in Poland in the frequency of the reported symptoms and in the conservative therapy of the chronic venous disease.


  • Trace Elements in the Wall of Abdominal Aortic Aneurysms With and Without Coexisting Iliac Artery Aneurysms

    by Damian Ziaja, Jerzy Chudek, Mariola Sznapka, Andrzej Kita, Grzegorz Biolik, Karolina Sieroń-Stołtny, Krzysztof Pawlicki, Jolanta Domalik, Krzysztof Ziaja


  • Assessment of subclinical acute kidney injury after abdominal aortic aneurysm surgery using novel markers: L-FABP and H-FABP

    by M Kokot, G Biolik, D Ziaja, T Fojt, L Kedzierski, Katarzyna Antoniak, Miroslawa Janowska, Krzysztof Pawlicki, Krzysztof Ziaja, Jan Dulawa

    One of the most severe complications of repair surgery for abdominal aortic aneurysms (AAA) is acute kidney injury (AKI). Even small rises in serum creatinine are associated with increased mortality. The aim of this study was to assess the dynamics of AKI after elective AAA surgery using novel markers. The study group consisted of 22 patients with AAA. We measured urinary liver- (u-L-FABP) and heart-type fatty acid-binding proteins (u-H-FABP) before, during and within 3 days after surgery. We found an abrupt and significant elevation of both urine FABPs normalized to urinary creatinine; u-L-FABP reached its peak value 2 hours after aortic clamp release {137.79 (38.57-451.79) vs. 9.94 (6.82-12.42) ng/mg baseline value, p<0.05; values are medians (lower-upper quartile)}. The peak value of u-H-FABP was reported 72 hours after aortic clamp release {16.462 (4.182-37.595) vs. 0.141 (0.014-0.927) ng/mg baseline value, p<0.05}. The serum creatinine level did not changed significantly during the investigation period. The significant rise of both u-L-FABP and u-H-FABP after AAA surgery indicates renal proximal and distal tubule injury in this population. Our results suggest that, after AAA surgery, the distal tubules could be more affected than the proximal ones. u-FABPs could serve as sensitive biomarkers of kidney tubular injury and may allow to detect the very early phases of AKI.


    • 1 January 2014
      • Vol. 18  (8) , 1176-80

    Neurological symptoms associated with cerebral hyperperfusion syndrome after CEA and CAS--one centre study.

    by D Ziaja, Grzegorz Biolik, Piotr Kocelak, M Sznapka, P Janas, A Czajka, Jerzy Chudek, K Ziaja

    There are two equivalent in efficacy methods of the treatment of carotid artery stenosis: endarterectomy (CEA) and stenting (CAS), in which the blood flow increases in most patients by 20-40% over baseline, in some exceeding 100% and being symptomatic and leading to cerebral hyperperfusion syndrome (CHS). The aim of this study is to analyze the structure of neurological symptoms associated with CHS in patients with carotid artery revascularization. Retrospective analysis included 1386 consecutive patients treated in the Department of General and Vascular Surgery between 2005 and 2011, with 625 of them were subjected to CEA and 761 to CAS. If neurological symptoms occurred, patients were consulted by a neurologist and ultrasonography (USG) examination and CT were performed. Neurological symptoms in patients with new onset of headache ipsilateral to the carotid revascularization were extracted from medical records and nursing documentation. Neurological symptoms attributed to CHS were observed in 66 (10.6%) of CEA and 61 (8.0 %) of CAS group. The frequency was similar in both groups (p = 0.43). The occurrence of epileptic attacks was similar in both study groups. The only difference was the less frequent falling of the lip in CAS group. Transient bradycardia and/or hypotension were observed in CAS (8.8% vs. 10.4% and 1.3% vs. 1.3%, respectively). No difference in stroke appearance between groups were found. The occurrence of neurological symptoms attributable to cerebral hyperperfusion syndrome after carotid artery revascularization in short term observation is similar regardless of the method used.